187 related articles for article (PubMed ID: 18261576)
1. Hyperuricemia influences chronic cyclosporine nephropathy.
Saglam F; Celik A; Sarioglu S; Cavdar C; Sifil A; Gulay H; Camsari T
Transplant Proc; 2008; 40(1):167-70. PubMed ID: 18261576
[TBL] [Abstract][Full Text] [Related]
2. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
4. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
5. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity.
Holzmacher R; Kendziorski C; Michael Hofman R; Jaffery J; Becker B; Djamali A
Nephrol Dial Transplant; 2005 Jul; 20(7):1456-62. PubMed ID: 15840674
[TBL] [Abstract][Full Text] [Related]
6. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
[TBL] [Abstract][Full Text] [Related]
7. Role of uric acid in post-renal transplantation hypertension.
Bandukwala F; Huang M; Prasad GV
Transplant Proc; 2009 Jun; 41(5):1634-6. PubMed ID: 19545696
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation.
Li Y; Xue WJ; Tian PX; Ding XM; Yan H; Pan XM; Feng XS
Transplant Proc; 2009 Jun; 41(5):1565-9. PubMed ID: 19545680
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
[TBL] [Abstract][Full Text] [Related]
10. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.
Shang MH; Yuan WJ; Zhang SJ; Fan Y; Zhang Z
Chin Med J (Engl); 2008 Jun; 121(11):983-8. PubMed ID: 18706245
[TBL] [Abstract][Full Text] [Related]
12. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
Akalin E; Ganeshan SV; Winston J; Muntner P
Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445
[TBL] [Abstract][Full Text] [Related]
14. The effect of sirolimus in the development of chronic allograft nephropathy.
Gürkan A; Kaçar S; Erdoğdu U; Varilsüha C; Kandemir G; Karaca C; Akman F
Transplant Proc; 2008; 40(1):114-6. PubMed ID: 18261561
[TBL] [Abstract][Full Text] [Related]
15. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
16. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
[TBL] [Abstract][Full Text] [Related]
17. Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.
Marcard T; Ivens K; Grabensee B; Willers R; Helmchen U; Rump LC; Blume C
Transpl Int; 2008 Dec; 21(12):1153-62. PubMed ID: 18684111
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
Ingsathit A; Sumethkul V; Chalermsanyakorn P; Jirasiritham S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S235-41. PubMed ID: 17044477
[TBL] [Abstract][Full Text] [Related]
20. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]